MSB 2.02% $1.01 mesoblast limited

Ann: MSB Reports Q3 Financial Results and Operational Highlights, page-265

  1. 7,913 Posts.
    lightbulb Created with Sketch. 627
    Again I feel as though nothing that has been said in the last few years has sunk in
    The Ryoncil phase 3 trial met it’s endpoints….so where do you link your theoretical failure of Mesoblast to Osiris to where we are now
    In fact I might opine that each trial has been a scientific journey of discovery and as a consequence the upcoming PDUFA date might usher a new form of medicine upon approval which is the complete opposite to what you just posted
    Last edited by stocksa: 28/05/23
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.01
Change
0.020(2.02%)
Mkt cap ! $1.158B
Open High Low Value Volume
99.5¢ $1.02 98.5¢ $1.404M 1.398M

Buyers (Bids)

No. Vol. Price($)
28 153147 $1.00
 

Sellers (Offers)

Price($) Vol. No.
$1.01 87053 21
View Market Depth
Last trade - 12.11pm 15/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.